interferon
ifn
pleotrop
cytokin
secret
upon
encount
pathogen
tumor
appli
antipathogen
antiprolif
immun
stimulatori
capac
recombin
ifn
frequent
prescrib
drug
treat
differ
diseas
ifn
act
chang
gene
express
profil
cell
due
characterist
rapid
gene
induct
signal
ifn
also
repres
prototyp
model
system
variou
aspect
biomed
research
eg
signal
transduct
regard
signal
activ
promot
ifn
subdivid
two
group
alter
cellular
proteom
human
cell
treat
elucid
timeresolv
manner
quantit
proteom
analysi
major
protein
regul
strongli
ifn
type
time
depend
addit
expect
upregul
ifnrespons
protein
astonish
number
protein
becam
profoundli
repress
especi
thu
comprehens
analysi
reveal
import
insight
human
ifnregul
proteom
dynam
protein
induct
repress
interestingli
new
class
ifnrepress
gene
compris
known
host
factor
highli
relev
pathogen
hiv
dengu
viru
hepat
c
viru
interferon
ifn
pleotrop
cytokin
secret
upon
encount
pathogen
tumor
appli
antipathogen
antiprolif
immun
stimulatori
capac
recombin
ifn
frequent
prescrib
drug
treat
differ
diseas
ifn
act
chang
gene
express
profil
cell
due
characterist
rapid
gene
induct
signal
ifn
also
repres
prototyp
model
system
variou
aspect
biomed
research
eg
signal
transduct
regard
signal
activ
promot
ifn
subdivid
two
group
alter
cellular
proteom
human
cell
treat
elucid
timeresolv
manner
quantit
proteom
analysi
major
protein
regul
strongli
ifn
type
time
depend
addit
expect
upregul
ifnrespons
protein
astonish
number
protein
becam
profoundli
repress
especi
thu
comprehens
analysi
reveal
import
insight
human
ifnregul
proteom
dynam
protein
induct
repress
interestingli
new
class
ifnrepress
gene
compris
known
host
factor
highli
relev
pathogen
hiv
dengu
viru
hepat
c
viru
keyword
interferon
ifnstimul
gene
ifnalpha
ifngamma
mass
spectrometri
proteom
ifnrepress
gene
introduct
interferon
ifn
pleiotrop
cytokin
rapidli
express
upon
encount
pathogen
virus
bacteria
fungi
presenc
tumor
mutat
impair
abil
stimul
ifn
secret
recogn
adequ
respond
ifn
drastic
consequ
term
exagger
pathogen
suscept
increas
tumor
frequenc
mice
harbor
target
mutat
central
compon
ifn
system
succumb
experiment
infect
variou
pathogen
even
low
dose
infect
sometim
rang
respect
detect
limit
even
wildtyp
anim
easili
surviv
infect
high
number
pathogen
human
individu
suffer
similar
mutat
identifiedoften
due
overt
morbid
mortal
infect
attenu
live
vaccin
virus
otherwis
mild
andor
opportunist
agent
import
ifn
control
tumor
evid
find
mice
lack
function
ifn
system
prone
spontan
tumor
develop
increas
tumor
burden
experiment
model
well
fact
lossoffunct
mutat
becom
enrich
gene
code
central
mediat
ifn
system
tumor
develop
eg
case
melanoma
indic
pronounc
select
pressur
elicit
ifn
system
interferon
influenc
numer
fundament
biolog
process
cell
prolifer
protein
translat
consist
express
ifn
profound
consequ
must
control
tightli
organ
level
ifn
treatment
often
associ
flulik
symptom
caus
signific
side
effect
eg
depress
excess
ifn
induct
andor
signal
due
mutat
result
diseas
call
interferonopathi
accord
molecular
homolog
receptor
usag
ifn
subdivid
type
type
ii
recent
describ
type
iii
ifn
type
ifn
compris
subclass
member
type
ii
ifn
ifnii
famili
type
iii
ifn
compris
sever
subtyp
differ
recombin
ifn
current
use
drug
human
combin
b
c
well
synthet
design
molecul
base
consensu
differ
subtyp
approv
fda
treat
differ
infecti
diseas
see
http
wwwaccessdatafdagovscriptscd
dafindexcfm
howev
frequent
prescrib
ifn
type
ifn
ifni
bind
receptor
complex
compos
preassoci
tyrosin
kinas
janu
kinas
respect
upon
bind
ifni
cognat
receptor
complex
janu
kinas
phosphoryl
intracellular
domain
receptor
chain
therebi
gener
bind
site
signal
transduc
activ
transcript
stat
stat
bound
receptor
becom
phosphoryl
specif
tyrosin
residu
locat
around
amino
acid
posit
case
due
intramolecular
interact
phosphoryl
tyrosin
residu
one
stat
molecul
src
homolog
domain
second
stat
molecul
vice
versa
activ
heterodim
form
previou
model
often
impli
de
novo
interact
monomer
stat
protein
upon
phosphoryl
wherea
recent
work
argu
favor
preform
stat
dimer
chang
conform
orient
upon
activ
togeth
ifn
regulatori
factor
form
activ
heterotrim
call
ifnstimul
gene
factor
transloc
nucleu
bind
specif
dna
enhanc
element
call
ifnstimul
respons
element
isr
induc
express
adjac
gene
bind
recognit
dna
mediat
stat
molecul
consist
central
part
isr
consensu
resembl
irf
dna
bind
site
also
call
irf
site
type
iii
ifn
shown
bind
distinct
receptor
complex
express
certain
tissu
induc
ifnilik
signal
therebi
similar
transcript
isr
respons
henc
type
type
iii
ifn
group
accord
activ
transcript
factor
complex
induc
gene
harbor
isr
promoterenhanc
element
interferon
bind
receptor
compos
preassoci
respect
clear
contrast
ifni
ifniii
mainli
induc
homodim
sinc
recognit
dna
reli
molecul
irf
molecul
respect
dna
enhanc
element
call
gammaactiv
sequenc
ga
repres
canon
stat
dnabind
site
differ
isr
element
ifn
respons
given
gene
consid
defin
presenc
well
number
distanc
arrang
isr
ga
enhanc
element
besid
two
canon
signal
pathway
activ
isr
ga
separ
type
iii
ifn
type
ii
ifn
sever
noncanon
signal
event
describ
exampl
ifni
induc
homodim
case
call
alpha
activ
factor
elicit
respons
induc
contain
complex
stimul
isrelik
respons
beneath
receptor
proxim
signal
event
crosstalk
also
induc
downstream
induct
second
layer
transcript
factor
eg
irf
strongli
induc
turn
enhanc
gene
harbor
irf
site
sinc
central
part
isr
element
resembl
irf
site
stimul
sever
ifni
respons
gene
indirectli
via
irf
like
given
descript
overlap
crosstalk
signal
cascad
surpris
cytokin
thought
induc
differ
biolog
respons
ifni
ifniii
believ
induc
direct
antivir
activ
wherea
mainli
consid
stimul
adapt
immun
respons
eg
enhanc
antigen
present
great
wealth
ifnstimul
gene
isg
describ
past
use
variou
techniqu
howev
other
provid
evid
especi
also
repress
transcript
consider
number
gene
term
ifnrepress
gene
irepg
find
rais
appar
relev
question
regul
result
alter
protein
composit
ifnexpos
cellsespeci
human
appli
labelfre
quantif
base
mass
spectrometri
determin
amplitud
dynam
ifninduc
chang
human
proteom
analyz
dynam
chang
elicit
comparison
isreactiv
ifn
sinc
ifni
ifniii
activ
similar
signal
cascad
focus
archetyp
ifn
due
promin
relev
antivir
drug
consist
reproduc
chose
diploid
human
cell
line
use
extens
gener
sever
vaccin
propag
sever
virus
lack
neoplast
properti
shown
sequenc
trypsin
set
cleav
enzym
one
allow
miss
cleavag
site
mass
area
set
da
mass
toler
ppm
precursor
da
fragment
ion
respect
oxid
methionin
set
dynam
modif
carbamidomethyl
cystein
static
confid
peptid
identif
assess
use
target
decoy
psm
valid
node
implement
proteom
discover
peptid
identif
fals
discoveri
rate
fdr
consid
protein
group
function
appli
quantit
data
analysi
perform
use
progenesi
qi
proteom
v
nonlinear
dynam
newcastl
upon
tyne
uk
briefli
lcmsm
run
import
align
master
mix
run
featur
detect
signal
least
three
isotop
charg
consid
delet
featur
satisfi
mention
criteria
raw
abund
featur
normal
correct
experiment
variat
subsequ
step
lcmsm
run
exhibit
normal
factor
consid
analysi
group
accord
experiment
group
identif
peptid
protein
obtain
map
respect
featur
import
result
file
proteom
discover
protein
quantif
conduct
use
nonconflict
peptid
protein
group
option
disabl
proteom
data
deposit
complet
submiss
proteomexchang
consortium
http
proteomecentr
proteomexchangeorg
via
pride
partner
repositori
data
set
identifi
doi
data
upload
use
proteomexchang
submiss
tool
ver
proconproteom
convers
tool
ver
use
necessari
convers
proteom
discover
result
file
mzidentml
standard
format
function
annot
perform
use
databas
annot
visual
integr
discoveri
david
ver
normal
protein
abund
export
progenesi
qi
arcsinhtransform
use
inhous
written
r
script
r
foundat
statist
comput
vienna
austria
benjaminihochberg
correct
oneway
anova
use
calcul
fdrcorrect
pvalu
protein
pass
signific
level
post
hoc
test
tukey
honest
signific
differ
method
conduct
obtain
pvalu
pairwis
comparison
immunoblot
immunoblot
perform
describ
previous
flow
cytometr
analysi
perform
describ
previous
use
herein
indic
antibodi
accord
studi
design
shown
figur
proteom
alter
human
cell
induc
analyz
mean
ionintensitybas
labelfre
quantit
proteom
elucid
timedepend
effect
protein
abund
chang
least
six
biolog
replic
rel
mocktreat
control
cell
monitor
h
whole
lcmsm
studi
protein
success
identifi
quantifi
least
one
uniqu
peptid
parallel
sampl
see
tabl
supplementari
materi
brief
inspect
correspond
name
protein
significantli
upregul
ifn
eg
ifninduc
gtpbind
protein
immedi
highlight
enrich
ifnstimul
protein
indic
valid
approach
cope
issu
less
accur
quantif
result
base
singl
peptid
quantif
determin
individu
coeffici
variat
cv
protein
repres
singl
uniqu
peptid
singl
peptid
quantif
larg
deviat
indic
averag
cv
exclud
comparison
median
cv
show
revis
group
protein
singl
peptid
quantif
exhibit
variat
observ
protein
quantifi
two
peptid
see
figur
supplementari
materi
number
protein
final
consid
data
analysi
concern
timeand
typedepend
proteom
alter
see
supplementari
materi
complet
data
set
quantit
statist
analys
number
protein
show
significantli
differ
abund
p
ifntreat
sampl
comparison
mocktreat
control
determin
ifn
type
incub
time
depend
ifn
type
durat
treatment
abund
protein
significantli
chang
see
number
bracket
figur
base
experi
limit
labelfre
quantif
criteria
biolog
signific
meaning
set
threshold
twofold
chang
term
median
protein
abund
see
number
without
bracket
figur
subsequ
analysi
sinc
chang
rather
arbitrarili
chosen
set
point
might
relev
particular
circumst
protein
includ
supplementari
materi
enabl
other
reanalyz
data
higher
lower
criteria
stringenc
depend
ifn
type
period
exposur
protein
significantli
chang
abund
twofold
highlight
profound
alter
cellular
protein
composit
respons
ifn
h
ifn
exposur
treatment
led
higher
number
protein
upregul
compar
versu
protein
clear
contrast
h
number
upregul
protein
five
eight
time
higher
case
versu
h
also
observ
sever
protein
significantli
downregul
respect
differ
even
pronounc
sinc
protein
regul
clearli
promin
upon
treatment
function
annot
protein
significantli
least
twofold
regul
perform
investig
time
point
obtain
result
display
broad
spectrum
associ
molecular
function
biolog
process
cellular
compon
see
figur
supplementari
materi
expect
ifn
type
ifn
signal
sever
relat
similar
gene
ontolog
call
eg
defens
respons
viru
found
highli
enrich
biolog
process
among
upregul
protein
addit
sever
biolog
process
associ
antigen
present
via
mhci
found
enrich
among
protein
induc
ifn
prolong
exposur
particular
case
obtain
result
furthermor
indic
broad
spectrum
divers
biolog
process
alter
line
expect
base
tremend
higher
number
protein
regul
compar
addit
dynam
natur
cellular
proteom
modul
nice
demonstr
enrich
particular
biolog
process
among
upand
downregul
protein
variou
time
point
exampl
differ
translat
process
found
highli
enrich
among
protein
h
wherea
process
enrich
group
protein
h
see
supplementari
materi
ensur
appropri
ifn
stimul
condit
valid
lcmsbase
result
prepar
lysat
subject
sd
page
subsequ
immunoblot
analysi
membran
probe
antibodi
specif
tyrosin
phosphoryl
activ
molecul
well
expect
ifntreat
induc
phosphoryl
led
increas
ifnrespons
gene
well
protein
figur
consist
notion
ifnrespons
eg
ref
other
protein
becam
also
upregul
exposur
result
obtain
lcmsbase
quantif
consist
result
obtain
immunoblot
figur
due
promin
role
protein
isglat
quantif
data
also
call
efp
also
call
also
depict
figur
interferon
differ
concern
biolog
respons
depend
natur
respect
pathogen
promin
discrep
concern
direct
antivir
activ
document
eg
accord
oversimplifi
textbook
concept
act
directli
antivir
eg
induc
effector
protein
mx
pkr
oa
wherea
modul
adapt
immun
respons
exampl
stimul
mhc
express
differ
reflect
nonoverlap
chang
proteom
therefor
ifn
typespecif
complementar
analyz
qualit
level
elucid
extent
ifn
regul
common
well
distinct
set
protein
end
list
protein
exhibit
signific
least
twofold
upand
downregul
treatment
respect
compar
time
point
analysi
result
shown
figur
protein
repress
protein
h
treatment
later
time
point
major
protein
respons
also
respons
top
commonli
respons
protein
capabl
specif
upregul
addit
protein
h
treatment
concern
downregul
protein
trend
even
pronounc
h
protein
respect
significantli
least
twofold
repress
wherea
also
repress
protein
plu
addit
protein
respect
figur
besid
qualit
assess
approach
also
allow
direct
quantit
comparison
chang
mean
correl
analys
therefor
compar
strength
regul
relat
strength
regul
scatter
plot
figur
contrast
previou
analysi
protein
show
significantli
alter
abund
upon
ifntreat
includ
irrespect
fold
chang
linear
regress
analys
investig
time
point
shown
figur
time
point
protein
least
twofold
regul
ifn
type
show
ident
regul
directiona
indic
appar
lack
protein
quadrant
ii
iv
figur
except
protein
specif
regul
least
twofold
one
ifn
type
exhibit
consist
signific
trend
upon
treatment
ifn
howev
latter
case
fold
chang
criteria
often
fulfil
regard
strength
regul
h
posttreat
slope
regress
line
indic
compar
induct
repress
effect
indic
slope
h
protein
regul
induc
pronounc
correspond
regul
elucid
timedepend
proteom
alter
observ
singl
ifn
type
protein
significantli
regul
least
twofold
h
posttreat
compar
result
accessionbas
comparison
depict
venn
diagram
figur
case
ifn
proteom
alter
found
highli
dynam
indic
distinct
complementar
investig
time
point
nucleat
cell
continu
present
snapshot
current
protein
express
profil
context
human
leukocyt
antigen
hla
molecul
circul
lymphocyt
see
figur
overview
especi
well
known
effect
sever
protein
implic
antigen
present
proteasom
proteas
degrad
protein
peptid
transfer
lumen
er
transport
associ
antigen
present
tap
via
tabbp
also
call
tapasin
tap
associ
hla
molecul
compos
hla
heavi
chain
load
peptid
onto
hlamhc
molecul
well
qualiti
control
catalyz
sever
chaperon
eg
calreticulin
calnexin
present
cell
surfac
cell
figur
valid
proteom
data
biolog
level
outlin
ifn
elicit
pronounc
antipathogen
activ
howev
ifni
ifnii
differ
rel
activ
certain
taxa
pathogen
antivir
activ
execut
multitud
effector
protein
thu
discrep
efficaci
differ
agent
must
also
reflect
differenti
express
relev
restrict
factor
base
global
data
set
chose
prototyp
exampl
ifnrespons
protein
document
antipathogen
activ
highlight
certain
protein
similarli
respons
ifn
wherea
either
induc
although
classic
antivir
gene
pkr
respond
consider
induct
becam
also
evid
upon
treatment
figur
left
panel
second
set
protein
previous
shown
antivir
activ
virus
hiv
influenza
eg
similarli
respons
ifn
figur
middl
panel
interestingli
third
class
protein
even
almost
exclus
respons
contain
protein
ido
pml
figur
right
panel
known
confer
antivir
activ
protein
assess
two
interest
trend
becam
appar
individu
protein
figur
b
ii
surprisingli
earli
time
point
condit
protein
exhibit
trend
toward
increas
protein
abund
figur
b
effect
also
prevail
global
level
protein
significantli
downregul
h
figur
h
figur
group
taken
togeth
herein
describ
data
set
uncov
sever
novel
insight
dynam
type
specif
proteom
alter
induc
ifn
constitut
ideal
start
point
mechanist
studi
eg
exact
signal
pathway
lead
repress
irepg
biolog
relev
defens
pathogen
tumor
analysi
establish
comprehens
catalog
protein
chang
abund
differ
time
period
ifni
andor
ifnii
exposur
studi
ifninduc
proteom
alter
perform
previouslyusu
appli
twodimension
gel
electrophoresi
subsequ
identif
individu
spot
differenti
regul
studi
one
ifn
type
one
time
point
specif
cellular
compart
assess
knowledg
present
first
studi
global
proteom
alter
induc
type
ii
ifn
directli
compar
cell
differ
time
point
fact
data
set
includ
six
eight
replic
condit
use
clinic
relev
subtyp
nontransform
cell
line
frequent
use
viru
vaccin
research
establish
data
set
refer
futur
studi
especi
pathogenor
tumorinduc
chang
cellular
proteom
quantifi
induct
ifn
subsequ
ifndepend
chang
obviou
confound
factor
comparison
herein
describ
data
set
allow
other
discrimin
ifndepend
ifnindepend
effect
pathogenspecif
chang
numer
studi
document
pronounc
antipathogen
antitumor
activ
ifn
howev
actual
effector
mechan
mostli
elus
case
herein
biolog
respons
ifn
type
differ
certain
virus
suscept
wherea
other
eg
mous
human
cytomegaloviru
well
vaccinia
viru
suscept
discrep
highlight
fact
individu
ifn
approv
treatment
defin
diseas
wherea
ifn
base
wealth
inform
crosstalk
signal
cascad
overlap
respons
certain
isg
biolog
differ
rather
puzzl
howev
compar
analysi
global
chang
within
proteom
fulli
consist
discrep
term
qualiti
quantiti
kinet
ifninduc
chang
differ
significantli
ifni
ifnii
effect
appar
repress
protein
almost
exclus
observ
respons
interestingli
although
data
uncov
remark
differ
ifn
class
incub
time
simpl
dichotomi
isreactiv
ifn
type
iii
act
directli
antivir
wherea
gasactiv
act
immunemodulatori
clearli
oversimplifi
induc
sever
direct
antivir
effector
protein
least
strong
even
stronger
addit
also
enhanc
compon
mhc
present
biolog
respons
ifn
influenc
abund
correspond
ifn
receptor
differenti
respons
toward
compar
might
influenc
differ
receptor
surfac
disposit
surfac
level
protein
determin
cytometri
use
antibodi
ligand
coupl
fluorophor
howev
antibodi
recogn
cognat
antigen
differ
affin
result
unavoid
bia
compar
quantif
differ
protein
similarli
msbase
determin
reli
differ
peptid
nonoverlap
characterist
identif
quantif
analysi
use
satur
ifn
concentr
depend
isg
irepg
subset
observ
pronounc
respons
either
see
figur
left
panel
figur
right
panel
ifn
figur
central
panel
indic
percept
cell
addit
find
differenti
respons
eg
gene
repress
irepg
stimul
observ
differ
level
protein
mrna
differ
speci
mous
human
differ
cell
type
macrophag
fibroblast
suggest
herein
describ
differ
rather
common
howev
might
certain
cell
type
heavili
skew
express
level
ifn
receptor
complex
might
depict
alter
respons
previou
transcript
analysi
murin
cell
reveal
exist
extend
set
irepg
mous
fibroblast
macrophag
irepg
respons
constitut
primari
transcript
respons
resist
blockad
translat
cycloheximid
align
irepg
promotersenhanc
result
enrich
ga
isr
element
instead
uncov
accumul
gcrich
element
correspond
bind
site
consist
previous
describ
depend
individu
gene
shown
repress
despit
lack
isr
ga
sequenc
irepg
repress
larg
lost
fibroblast
suggest
gene
repress
mostli
neglect
abil
signatur
transcript
factor
data
immedi
rais
two
import
question
pose
import
futur
question
concern
biolog
signific
irepg
term
respons
pathogen
tumor
difficult
imagin
ifninduc
downregul
protein
requir
replic
certain
pathogen
tumor
might
benefit
hostsimpli
withhold
essenti
cofactor
eg
entri
receptor
intracellular
pathogen
prevent
infect
virus
also
reli
numer
intracellular
factor
metabol
capabl
host
cell
allow
replic
one
unifi
featur
virus
lack
ribosom
thu
inabl
translat
protein
outsid
host
cell
consist
translat
machineri
one
major
battleground
pathogen
host
sever
isg
eg
pkr
target
translat
review
ref
downregul
protein
requir
translat
essenti
metabol
pathway
atp
synthesi
might
limit
replic
pathogen
consist
observ
eg
other
repress
see
data
sheet
supplementari
materi
thu
seem
irepg
contribut
restrict
translat
machineri
seemingli
suicid
aspect
repress
might
overcom
strictli
control
regul
ifn
upon
infect
question
aris
find
defin
host
factor
amongst
ifnrepress
protein
one
protein
downregul
fatti
acid
synthas
fasn
protein
id
figur
differ
studi
fasn
known
requir
replic
hepat
c
viru
dengu
viru
respiratori
syncyti
viru
human
parainfluenza
astroviru
rhinoviru
replic
therefor
tempt
specul
suppress
fasn
might
reduc
replic
virus
anoth
exampl
protein
requir
replic
arena
corona
filovirus
found
repress
function
studi
irepg
definit
need
comparison
herein
found
irepg
gene
found
least
two
three
publish
sirna
screen
requir
hiv
replic
indic
famili
irepg
also
compris
addit
gene
requir
hiv
replic
eg
anoth
protein
significantli
downregul
protein
id
interestingli
recent
shown
promot
epithelialmesenchym
transit
lung
cancer
progress
therefor
also
tempt
specul
thisor
similar
effectsof
protein
repress
might
also
contribut
antitumor
effect
ifn
howev
remain
elucid
futur
extent
mechan
irepg
exactli
contribut
known
properti
antivir
antibacteri
antiprolif
antitumor
immunestimulatori
effect
ifn
mayb
sideeffect
induc
ifn
treatment
find
ifnrepress
protein
significantli
downregul
upon
h
treatment
show
slightli
increas
abund
h
ifn
first
glanc
challeng
reconcil
futur
studi
requir
elucid
involv
molecular
event
transcript
factor
lead
gene
repress
ifn
interest
futur
question
regard
contribut
transcript
chang
comparison
alter
protein
stabil
take
previou
find
irepg
observ
level
nascent
mrna
effect
larg
depend
well
herein
describ
earli
induct
account
potenti
explan
might
base
neg
feedback
regul
ifn
well
known
ifn
limit
signal
stimul
potent
mediat
neg
feedback
loop
eg
ifninduc
express
suppressor
cytokin
signal
protein
inhibitor
activ
stat
hypothes
irepg
might
weakli
ifn
respons
fulli
respons
effect
neg
feedback
cascad
infer
respons
protein
repressor
transcript
ii
ifninduc
iii
abl
identifi
irepg
besid
three
promis
candid
mechan
three
protein
bind
dna
repress
transcript
induc
ifn
recogn
isr
irf
ga
similar
dna
element
taken
togeth
analysi
provid
comprehens
catalog
ifninduc
chang
human
proteom
remark
differ
term
proteom
chang
induc
becam
evidentespeci
upon
prolong
exposur
proteom
ifnstimul
cell
chang
dramat
durat
ifn
stimul
highlight
necess
perform
experi
biolog
respons
compar
protein
express
data
adequ
tempor
